ABOUT US
At Aviadobio, we are guided by our hearts and minds
Our purpose is to transform the lives of people living with some of the most debilitating and life-threatening neurodegenerative disorders, such as frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), through the potential of gene therapy.
OUR HERITAGE
We are building on pioneering research from King’s College London and the UK Dementia Research Institute (UK DRI).
Download Our About AviadoBio Company Overview
SCIENTIFIC CO-FOUNDERS
Prof Chris Shaw
Co-Founder
Youn Bok Lee, PhD
Co-Founder
Do Young Lee, PhD
Co-Founder
OUR INVESTORS
“Our achievements would not be possible without the outstanding team that make up AviadoBio. We are united by a common purpose that brings together different talents, backgrounds and experiences to deliver on our promise to patients and their families. We are set out to make a difference – one that we can tangibly see.”
Graeme Fielder, PhD
Chief Operating Officer
Graeme Fielder, PhD
Chief Operating Officer
OUR VALUES
Unity
One team, aligned around a common purpose to transform the lives of people living with debilitating neurodegenerative disorders.
Relentless
Bold and tenacious. We act with urgency and won’t stop until we can better serve those counting on us.
Integrity
We take the ‘right’ path not the ‘easy’ path.
Compassionate
People are at the heart of everything we do.
Join our neural navigators
You’ll be joining an energized team with a single focus dedicated to the needs of helping people living with cruel and debilitating neurodegenerative disorders through the potential of gene therapy.
Our achievements would not be possible without the outstanding team that make up AviadoBio.
